Beta Sense
betaSENSE develops an innovative platform technology for the precise detection of misfolded biomarker proteins in bodily fluids. This capability enables the early diagnosis of neurodegenerative diseases like Alzheimer's and Parkinson's before irreversible brain damage occurs. The resulting early detection facilitates timely intervention through lifestyle adjustments and medication, supporting patient self-determination in old age.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- betaSENSE develops an innovative platform technology for the precise detection of misfolded biomarker proteins in bodily fluids. This capability enables the early diagnosis of neurodegenerative diseases like Alzheimer's and Parkinson's before irreversible brain damage occurs. The resulting early detection facilitates timely intervention through lifestyle adjustments and medication, supporting patient self-determination in old age.